News

RBC Capital Maintains a Buy Rating on Dyne Therapeutics (DYN) With a $25 PT
Dyne Therapeutics, Inc. (NASDAQ:DYN) is one of the 13 Best Healthcare Stocks to Buy Under $10. In a report released on July 7, Luca Issi from RBC Capital maintained a Buy rating on Dyne Therapeutics, ...
I’m a beauty expert: Try these budget-friendly skincare products costing under £30 that are as good as their pricier rivals - and this is how to get the best results from t…
Mail journalists select and curate the products that feature on our site. If you make a purchase via links on this page we ...